Byonyks X1: a New, Small, Portable APD Machine
Developed in Pakistan with U.S. R&D, an FDA application for the X1 was filed in Nov., 2023. Byonyks expects the X1 to be in patients’ homes in 2025. Later, the X2 and X3 will provide PD using ultrapure dialysate made on demand, which will reduce supply storage and delivery costs, as well as medical waste. Watch the 9-minute pitch video.
Read the full article » | Posted 06-14-2024
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

